Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Molecular Partners AG

MLLCF•PNK
Healthcare
Biotechnology
$3.50
$1.25(55.56%)
U.S. Market opens in 9h 43m

Molecular Partners AG (MLLCF) Stock Overview

Explore Molecular Partners AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap130.9M
P/E Ratio-1.68
EPS (TTM)$-2.10
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 Month$2.39
3 Months$2.21
1 Year Target$2.48

MLLCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Molecular Partners AG (MLLCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 5.40, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $2.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.68 and a market capitalization of 130.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
55.56%
1-Month Change
N/A
3-Month Change
-2.78%
6-Month Change
-17.06%
Year-to-Date (YTD) Change
N/A
1-Year Change
-17.06%
3-Year Change
-39.66%
5-Year Change
-86.67%
All-Time (Max) Change
-84.53%

Contact Information

https://www.molecularpartners.com
41 44 755 77 00
Wagistrasse 14, Schlieren, NaN, 8952

Company Facts

1,580 Employees
IPO DateJun 14, 2018
CountryCH
Actively Trading

Frequently Asked Questions